MARATTO

article · Frontiers in Scientific Research and Technology

Nanocomposite for Enhancement the Biological Activity of Cu(II)-complex from New Cefotaxime Derivative

20234 citationsOpen accessSuez University

Abstract

A novel cefotaxime derivative, Schiff base ligand, is used to create copper complex. Molar conductivity, elemental study, Infrared, uv-vis spectra, magnetic moment, and thermal behavior are used to describe the complex. The compound molar ratio is discovered to be one metal to one ligand. The infrared bands show that the Schiff base binds copper ion as tridentate via carboxylate, acetylacetone carbonyl and imine group.The magnetic moment, uv-vis transitions, and ESR spectrum, on the other hand, show that the CuII-complex structure is octahedral. Thermal analysis also reveals the presence of water and methyl alcohol in the compound. Moreover, Sol-gel process is utilized for silica nanoparticles preparation. While, the complex is loaded on silica nanoparticles after surface modification. Whereas, the CuII-complex and nano-complex are tested for Gram (+) (B. subtilis and S. aureus) and Gram (-) (E. coli and P. aeruginosa) microbes. The biological results exposed that the synthesized complex has high potential to overcome the resistance of microbes.

Research topics

  • Nanoparticle-Based Drug Delivery
  • Computational Drug Discovery Methods
  • Synthesis of Tetrazole Derivatives

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/fsrt.2023.195650.1086

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.